The distribution of COVID-19 vaccination among nations has gone towards vaccination nationalism, in which countries hoard vaccinations to prioritize accessibility to their citizens over equal vaccination distribution. As per a Princeton University and McGill University research published Aug. 17 in the journal Science, the level of vaccination nationalist could have a significant effect on global trends of COVID-19 incidence counts and boost the possible development of unique variations.

Buying Up Vaccinations By Countries May Result In A Rise In COVID-19 Cases


The vaccine is the only option to save the people from the infection that is rapidly spread by the coronavirus but storage of the same with a few countries may leave many needy people without any option and vulnerable to the infection. It will not end here as the virus will still exist and hence prudential distribution among different countries by makers is a much-needed action at this moment. It must reach every individual to counter the virus irrespective of nation and number of cases.
“Countries with severe COVID-19 outbreaks, such as Peru and South Africa, have received few vaccine doses, whereas many doses have gone to countries with comparatively milder pandemic impacts, either in terms of mortality or economic dislocation,” said co-first author Caroline Wagner, an associate dean of bioengineering at McGill University who recently worked as a post doctorate researcher.

Buying Up Vaccinations By Countries May Result In A Rise In COVID-19 Cases And The Creation Of Novel Variants


“As expected, we’ve seen large reductions in case of numbers in many regions with high vaccine access, but infections are resurging in areas where vaccines are scarce,” said co-first author Chadi Saad-Roy, a Princeton grad student in ecosystems and evolutionary psychology and the Lewis-Sigler Implement for Interdisciplinary Genomics.
“We used mathematical models to investigate the implications of different vaccine-sharing strategies on the worldwide persistence of COVID-19 infections as well as the probability of novel variant evolution,” Saad-Roy stated.
“We were able to analyze the reliance of our epidemiological estimates on different immunological parameters, area characteristics such as population size and local transmission rate, and our vaccine allocation assumptions in this way,” Wagner explained.
“High case numbers in unvaccinated populations will likely be associated with higher numbers of hospitalizations and larger clinical burdens compared to highly vaccinated populations,” said senior author C. Jessica E. Metcalf, a Princeton assistant professor of ecology and evolutionary biology and public affairs and affiliated faculty in HMEI.
The researchers also used a methodology they built before to try to evaluate the possibility for viral mutation under various vaccination distribution strategies. Repeated infection in people with limited immunity either with a previous illness or a vaccine could lead to the emergence of new variations, according to their hypothesis.
“Overall, the models predict that high case numbers in LARs with limited vaccine availability will result in a high potential for viral evolution,” said senior author Bryan Grenfell, the Kathryn Briger and Sarah Fenton Professor of Ecology and Evolutionary Biology and Public Affairs at Princeton and an associated faculty member in HMEI.
“Like our previous research, the latest study emphasizes the importance of quick, equitable worldwide vaccine distribution,” Grenfell added. “Unequal vaccine allocation appears particularly worrisome in a feasible scenario where secondary infections in previously infected individuals greatly contribute to virus development.”
According to co-author Ezekiel Emanuel, the Diane V.S. Levy, and Robert M. Levy University Chair and co-director of the University of Pennsylvania’s Healthcare Transformation Institute there are many additional issues for vaccination fairness outside epidemiologic and adaptive considerations.
The timing of when vaccinations are shared, according to co-author Jeremy Farrar, a director is also likely to be critical: “In particular, sharing in parallel is what makes the most impact, not in sequence.”